<?xml version="1.0" encoding="UTF-8"?>
<ref id="fcaa031-B80">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Simon</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Eberly</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gao</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Oakes</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tanner</surname>
    <given-names>CM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shoulson</surname>
    <given-names>I</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>; on behalf of the Parkinson Study Group. 
  <article-title>Mendelian randomization of serum urate and Parkinson disease progression</article-title>. 
  <source>Ann Neurol</source>
  <year>2014</year>; 
  <volume>76</volume>: 
  <fpage>862</fpage>â€“
  <lpage>8</lpage>.
  <pub-id pub-id-type="pmid">25257975</pub-id>
 </mixed-citation>
</ref>
